AREV Life Sciences Global Corp. (AREVF)
OTCMKTS · Delayed Price · Currency is USD
0.0100
0.00 (0.00%)
At close: Jan 27, 2025
AREV Life Sciences Global Market Cap
AREV Life Sciences Global has a market cap or net worth of $317.62 thousand as of July 29, 2025. Its market cap has decreased by -95.89% in one year.
Market Cap
317.62K
Enterprise Value
423.81K
Revenue
5.33K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since April 30, 2019, AREV Life Sciences Global's market cap has decreased from 11.74M to 317.62K, a decrease of -97.29%. That is a compound annual growth rate of -46.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 27, 2025 | 317.62K | -87.64% |
| Dec 30, 2022 | 2.57M | -64.99% |
| Dec 31, 2021 | 7.34M | 67.34% |
| Dec 31, 2020 | 4.39M | 124.09% |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 30, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.81B |
| Veradigm | 789.71M |
| Nika Pharmaceuticals | 708.22M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 590.95M |
| Glass House Brands | 435.80M |
| Northwest Biotherapeutics | 379.00M |
| CytoDyn | 371.09M |